SCHEMBL6361111

SCHEMBL6361111

COc1ccc2c(c1)c(CC(=O)OCCOC(=O)N1CCOCC1)c(C)n2C(=O)c1ccc(Cl)cc1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 15/20 0.81
CNR2 P34972 3/20 0.77
PKM P14618 2/20 0.77
MEN1 O00255 1/20 0.77
GMNN O75496 1/20 0.77
CYP1A2 P05177 1/20 0.77
CYP3A4 P08684 1/20 0.77
CYP2C9 P11712 1/20 0.77
TSHR P16473 1/20 0.77
NFKB1 P19838 1/20 0.77
CYP2C19 P33261 1/20 0.77
BLM P54132 1/20 0.77
PMP22 Q01453 1/20 0.77
KMT2A Q03164 1/20 0.77
CNR1 P21554 1/20 0.69
AKR1C3 P42330 1/20 0.67
HTR1A P08908 1/20 0.67
PTGS1 P23219 1/20 0.67
GLO1 Q04760 1/20 0.67
HIF1A Q16665 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Indomethacin Morpholinylamide SCHEMBL8314320 0.87 CNR2 (1.00) PTGS2CNR2PKMMEN1GMNN
Indomethacin Morpholinylamide SCHEMBL29358919 0.87 CNR2 (1.00) PTGS2CNR2PKMMEN1GMNN
SCHEMBL6361108 0.87 CNR2 (0.75) PTGS2CNR2PKMMEN1GMNN
SCHEMBL30077218 0.86 PTGS2 (0.91) PTGS2CNR2PKMMEN1CYP1A2
SCHEMBL12742120 0.86 PTGS2 (0.91) PTGS2CNR2PKMMEN1CYP1A2
SCHEMBL11174704 0.84 PTGS2 (0.85) PTGS2CNR2PKMMEN1CYP1A2
SCHEMBL13813542 0.84 PTGS2 (1.00) PTGS2CNR2PKMMEN1CYP1A2
SCHEMBL1394516 0.84 PTGS2 (0.81) PTGS2CNR2PKMMEN1CYP1A2
SCHEMBL19376389 0.83 PTGS2 (0.84) PTGS2CNR2PKMMEN1CYP1A2
SCHEMBL16008849 0.83 PTGS2 (0.84) PTGS2CNR2PKMMEN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050004118-A1 Prodrugs of non-steroidal anti-inflammatory and carboxylic acid containing compounds JILANI JAMAL A (JO) 2005-01-06 US claimed
US-20030060465-A1 Prodrugs of non-steroidal anti-inflammatory and carboxylic acid containing compounds SPECIALIZED PHARMACEUTICAL RESEARCH LTD. CO. (JO) 2003-03-27 US claimed
EP-1231209-A1 Prodrugs of non-steroidal anti-inflammatory and carboxylic acid containing compound Specialized Pharmaceutical Research Ltd. Co. (JO) 2002-08-14 EP claimed
US-20050004118-A1 Prodrugs of non-steroidal anti-inflammatory and carboxylic acid containing compounds JILANI JAMAL A (JO) 2005-01-06 US disclosed
US-20030060465-A1 Prodrugs of non-steroidal anti-inflammatory and carboxylic acid containing compounds SPECIALIZED PHARMACEUTICAL RESEARCH LTD. CO. (JO) 2003-03-27 US disclosed
EP-1231209-A1 Prodrugs of non-steroidal anti-inflammatory and carboxylic acid containing compound Specialized Pharmaceutical Research Ltd. Co. (JO) 2002-08-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004118-A1 Prodrugs of non-steroidal anti-inflammatory and carboxylic acid containing compounds HCAR2, NONO, ALOX15 PTGS2 14/4885CNR2 73/4885PKM 3783/4885
US-20030060465-A1 Prodrugs of non-steroidal anti-inflammatory and carboxylic acid containing compounds NONO, CCNO, HCAR2 PTGS2 14/4885CNR2 147/4885PKM 3947/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.